Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 1/2011

01.02.2011 | Original Paper

Validity of the Definite and Semidefinite Questionnaire version of the Hamilton Depression Scale, the Hamilton Subscale and the Melancholia Scale. Part I

verfasst von: Jesper Bent-Hansen, Per Bech

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Instruments for self-rating in depression are available, but their psychometric properties have not been fully explored; discrepancies with clinician ratings have been identified. This study was longitudinal with 85 patients fulfilling the DSM-III-R diagnosis of Seasonal Affective Disorder. Self-reporting versions (definitely and semidefinitely anchored) corresponding to the Hamilton Depression Scale (HAMD), the Hamilton Subscale (HAM6), and the Bech–Rafaelsen Melancholia Scale (MES) were compared to each other and the clinician-rated version. The unidimensional property of the sum score in each scale was tested by the item-response theory model ad modum Rasch. The scales were also tested for their sensitivity to discriminate between placebo and citalopram therapy. The sum scores and the sum score variances of the definite self-rating versions did not differ significantly from the sum scores of the corresponding observer scales at any of the five time points. The semidefinite scales significantly over-scored at all time points. The convergent validity between corresponding definite self-ratings and observer ratings was very high with correlations exceeding 0.90. Only item responses from the MES, the HAM6, and their corresponding definite versions of the self-rating questionnaires DMQ and DHAM6 were accepted by the Rasch analysis, and only these four valid scales discriminated significantly between the effect of citalopram and placebo treatment. Our results are limited to patients with moderate depression. Two new self-report scales with unparalleled construct validity, reliability, sensitivity, and convergent validity have been identified (DMQ and DHAM6). We have also identified a crucial importance of format for the means and variances of self-rating scales. These findings are of high practical and scientific value.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ajdacic-Gross V, Vetter S, Müller M, Kawohl W, Frey F, Lupi G, Blechschmidt A, Born C, Latal B, Rössler W (2009) Risk factors for stuttering: a secondary analysis of a large data base. Eur Arch Psychiatry Clin Neurosci Published online: 15 Oct 2009 Ajdacic-Gross V, Vetter S, Müller M, Kawohl W, Frey F, Lupi G, Blechschmidt A, Born C, Latal B, Rössler W (2009) Risk factors for stuttering: a secondary analysis of a large data base. Eur Arch Psychiatry Clin Neurosci Published online: 15 Oct 2009
3.
Zurück zum Zitat Armitage P, Berry G, Matthews JNS (2002) Statistical methods in medical research, 4th edn. Blackwell Scientific Publications, London, pp 203–204 Armitage P, Berry G, Matthews JNS (2002) Statistical methods in medical research, 4th edn. Blackwell Scientific Publications, London, pp 203–204
4.
Zurück zum Zitat Bagby RM, Ryder AG, Schuller DR, Marshall MB (2004) The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 161:2163–2177CrossRefPubMed Bagby RM, Ryder AG, Schuller DR, Marshall MB (2004) The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 161:2163–2177CrossRefPubMed
5.
Zurück zum Zitat Bech P (1981) Rating scales for affective disorders: their validity and consistency. Thesis. Acta Psychiatr Scand 64(Suppl 295):1–101 Bech P (1981) Rating scales for affective disorders: their validity and consistency. Thesis. Acta Psychiatr Scand 64(Suppl 295):1–101
6.
Zurück zum Zitat Bech P, Kastrup M, Rafaelsen OJ (1986) Mini-compendium of rating scales for states of anxiety, depression, mania and schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand 73(Suppl 326):1–37 Bech P, Kastrup M, Rafaelsen OJ (1986) Mini-compendium of rating scales for states of anxiety, depression, mania and schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand 73(Suppl 326):1–37
7.
Zurück zum Zitat Bech P (1993) Rating scales for psychopathology, health status and quality of life: a compendium on documentation in accordance with the DSM 3-R and WHO systems. Springer, Berlin Bech P (1993) Rating scales for psychopathology, health status and quality of life: a compendium on documentation in accordance with the DSM 3-R and WHO systems. Springer, Berlin
8.
Zurück zum Zitat Bech P (2002) The Bech–Rafaelsen melancholia Scale (MES) in clinical trials of therapies in depressive disorders: a 20-year review of its use as outcome measure. Acta Psychiatr Scand 106:252–264CrossRefPubMed Bech P (2002) The Bech–Rafaelsen melancholia Scale (MES) in clinical trials of therapies in depressive disorders: a 20-year review of its use as outcome measure. Acta Psychiatr Scand 106:252–264CrossRefPubMed
9.
Zurück zum Zitat Beck AT, Ward CH, Mendelson M, Mock ErbaughJ (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMed Beck AT, Ward CH, Mendelson M, Mock ErbaughJ (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMed
10.
Zurück zum Zitat BenjaminiY HochbergY (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B 57:289–300 BenjaminiY HochbergY (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B 57:289–300
11.
Zurück zum Zitat Bent-Hansen J, Kørner A, Lauritzen L, Clemmesen L, Lunde M (1995) A definite and a semidefinite questionnaire version of the Hamilton/Melancholia (HAMD/MES) scale. J Affect Disord 33:143–150CrossRefPubMed Bent-Hansen J, Kørner A, Lauritzen L, Clemmesen L, Lunde M (1995) A definite and a semidefinite questionnaire version of the Hamilton/Melancholia (HAMD/MES) scale. J Affect Disord 33:143–150CrossRefPubMed
12.
Zurück zum Zitat Caroll BJ, Feinberg M, Smouse PE, Rawson SG, Greden JF (1981) The Carroll Rating Scale for depression 1. Development, reliability and validation. Br J Psychiatry 138:194–200CrossRef Caroll BJ, Feinberg M, Smouse PE, Rawson SG, Greden JF (1981) The Carroll Rating Scale for depression 1. Development, reliability and validation. Br J Psychiatry 138:194–200CrossRef
13.
Zurück zum Zitat Demyttenaere K, Fruyt JD (2003) Getting what you ask for: on the Selectivity of Depression Rating Scales. Psychother Psychosom 72:61–70CrossRefPubMed Demyttenaere K, Fruyt JD (2003) Getting what you ask for: on the Selectivity of Depression Rating Scales. Psychother Psychosom 72:61–70CrossRefPubMed
14.
Zurück zum Zitat Domken M, Scott J, Kelly P (1994) What factors predict discrepancies between self- and observer-ratings of depression? J Affect Disord 31:253–259CrossRefPubMed Domken M, Scott J, Kelly P (1994) What factors predict discrepancies between self- and observer-ratings of depression? J Affect Disord 31:253–259CrossRefPubMed
15.
Zurück zum Zitat Faravelli C, Albanesi G, Poli E (1986) Assessment of depression: a comparison of rating scales. J Affect Disord 11:245–253CrossRefPubMed Faravelli C, Albanesi G, Poli E (1986) Assessment of depression: a comparison of rating scales. J Affect Disord 11:245–253CrossRefPubMed
16.
Zurück zum Zitat Feinberg M, Carroll BJ, Smouse P, Rawson S (1981) The Caroll Rating Scale for depression 3. Comparison with other rating instruments. Br J Psychiatry 138:205–209CrossRefPubMed Feinberg M, Carroll BJ, Smouse P, Rawson S (1981) The Caroll Rating Scale for depression 3. Comparison with other rating instruments. Br J Psychiatry 138:205–209CrossRefPubMed
17.
18.
Zurück zum Zitat Hamilton M (1967) Development of a rating sale for primary depressive illness. Br J Soc Clin Psychol 6:278–296PubMed Hamilton M (1967) Development of a rating sale for primary depressive illness. Br J Soc Clin Psychol 6:278–296PubMed
19.
Zurück zum Zitat Kellner R (1986) The symptom rating test. In: Sartorius N, Ban TA (eds) Assessment of depression. Springer, Berlin, pp 213–220 Kellner R (1986) The symptom rating test. In: Sartorius N, Ban TA (eds) Assessment of depression. Springer, Berlin, pp 213–220
20.
Zurück zum Zitat Keselman HJ, Cribbie R, Holland B (2002) Controlling the rate of Type I error over a large set of statistical tests. Br J Math Stat Psychiatry 55:27–39CrossRef Keselman HJ, Cribbie R, Holland B (2002) Controlling the rate of Type I error over a large set of statistical tests. Br J Math Stat Psychiatry 55:27–39CrossRef
22.
Zurück zum Zitat Lecrubier Y, Bech P (2007) The Ham D6 is more homogeneous and as sensitive as the HamD17. European Psychiatry 22:252–255CrossRefPubMed Lecrubier Y, Bech P (2007) The Ham D6 is more homogeneous and as sensitive as the HamD17. European Psychiatry 22:252–255CrossRefPubMed
23.
Zurück zum Zitat Ludbrook J (1998) Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 25:1032–1037CrossRefPubMed Ludbrook J (1998) Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 25:1032–1037CrossRefPubMed
24.
Zurück zum Zitat Maier W, Philipp M, Heuser I (1988) Improving depression severity assessment-I. Reliability internal validity and sensitivity to change of three observer depression scales. J Psychiatr Res 22:3–12CrossRefPubMed Maier W, Philipp M, Heuser I (1988) Improving depression severity assessment-I. Reliability internal validity and sensitivity to change of three observer depression scales. J Psychiatr Res 22:3–12CrossRefPubMed
25.
Zurück zum Zitat Martiny K, Lunde M, Simonsen C, Clemmesen L, Poulsen DL, Solstad K, Bech (2004) Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo-controlled study. Acta Psychiatr Scand 109:230–234CrossRefPubMed Martiny K, Lunde M, Simonsen C, Clemmesen L, Poulsen DL, Solstad K, Bech (2004) Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo-controlled study. Acta Psychiatr Scand 109:230–234CrossRefPubMed
26.
Zurück zum Zitat Miller PR, Dasher R, Collins R, Griffiths P, Brown F (2001) Inpatient diagnostic assessments: 1. Accuracy of structured vs. unstructured interviews. Psychiatry Res 105:255–265CrossRefPubMed Miller PR, Dasher R, Collins R, Griffiths P, Brown F (2001) Inpatient diagnostic assessments: 1. Accuracy of structured vs. unstructured interviews. Psychiatry Res 105:255–265CrossRefPubMed
27.
Zurück zum Zitat Mulsant BH, Kastango KB, Rosen J, Stone RA, Mazumdar S, Pollock BG (2002) Interrater reliability in clinical trials of depressive disorders. Am J Psychiatry 159:1598–1600CrossRefPubMed Mulsant BH, Kastango KB, Rosen J, Stone RA, Mazumdar S, Pollock BG (2002) Interrater reliability in clinical trials of depressive disorders. Am J Psychiatry 159:1598–1600CrossRefPubMed
28.
Zurück zum Zitat Möller HJ (2001) Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale. Eur Arch Psychiatry Clin Neurosci 251(Suppl 2):13–20CrossRef Möller HJ (2001) Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale. Eur Arch Psychiatry Clin Neurosci 251(Suppl 2):13–20CrossRef
29.
Zurück zum Zitat Möller HJ, Broich K (2009) Principle standards and problems regarding proof of efficacy in clinical psychopharmachology. Eur Arch Psychiatry Clin Neurosci Published online: 04 Nov 2009 Möller HJ, Broich K (2009) Principle standards and problems regarding proof of efficacy in clinical psychopharmachology. Eur Arch Psychiatry Clin Neurosci Published online: 04 Nov 2009
30.
Zurück zum Zitat Overall JE, Doyle SR (1994) Implications of chance baseline differences in repeated measurement designs. J Biopharm Stat 4:199–216CrossRefPubMed Overall JE, Doyle SR (1994) Implications of chance baseline differences in repeated measurement designs. J Biopharm Stat 4:199–216CrossRefPubMed
31.
Zurück zum Zitat Pocock SJ, Assmann SE, Enos LE, Kasten LE (2002) Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med 21:2917–2930CrossRefPubMed Pocock SJ, Assmann SE, Enos LE, Kasten LE (2002) Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med 21:2917–2930CrossRefPubMed
32.
Zurück zum Zitat Rasch G (1980) Probabilistic models for some intelligence and attainment tests. University of Chicago Press, Chicago Rasch G (1980) Probabilistic models for some intelligence and attainment tests. University of Chicago Press, Chicago
33.
Zurück zum Zitat Rush AJ, Hiser W, Giles D (1987) A comparison of self-reported versus clinician-rated symptoms in depression. J Clin Psychiatry 48:246–248PubMed Rush AJ, Hiser W, Giles D (1987) A comparison of self-reported versus clinician-rated symptoms in depression. J Clin Psychiatry 48:246–248PubMed
34.
Zurück zum Zitat SAS Documentation (software version 9.1). The mixed linear model for repeated data SAS Documentation (software version 9.1). The mixed linear model for repeated data
35.
Zurück zum Zitat Senra C, Polaino A (1993) Concordance between clinical and self-report depression scales during the acute phase and after treatment. J Affect Disord 27:13–20CrossRefPubMed Senra C, Polaino A (1993) Concordance between clinical and self-report depression scales during the acute phase and after treatment. J Affect Disord 27:13–20CrossRefPubMed
36.
Zurück zum Zitat Tondo L, Burrai C, Scamonatti L, Weissenburger J, Rush AJ (1988) Comparison between clinician-rated and self-reported depressive symptoms in Italian psychiatric patients. Neuropsychobiology 19:1–5CrossRefPubMed Tondo L, Burrai C, Scamonatti L, Weissenburger J, Rush AJ (1988) Comparison between clinician-rated and self-reported depressive symptoms in Italian psychiatric patients. Neuropsychobiology 19:1–5CrossRefPubMed
37.
Zurück zum Zitat Williams JB, Link MJ, Rosenthal NE, Terman M (1988) Structured Interview guide for the Hamilton Depression rating Scale, Seasonal Affective Disorders Version (SIGH-SAD). New York Psychiatric Institute, New York Williams JB, Link MJ, Rosenthal NE, Terman M (1988) Structured Interview guide for the Hamilton Depression rating Scale, Seasonal Affective Disorders Version (SIGH-SAD). New York Psychiatric Institute, New York
38.
Zurück zum Zitat Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGrawHill, New York, pp 289–296 Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGrawHill, New York, pp 289–296
Metadaten
Titel
Validity of the Definite and Semidefinite Questionnaire version of the Hamilton Depression Scale, the Hamilton Subscale and the Melancholia Scale. Part I
verfasst von
Jesper Bent-Hansen
Per Bech
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 1/2011
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-010-0106-1

Weitere Artikel der Ausgabe 1/2011

European Archives of Psychiatry and Clinical Neuroscience 1/2011 Zur Ausgabe

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.